ArticleInternational journal of methods in psychiatric research2026
Association Between Cerebrospinal Fluid Ghrelin Levels and Depressive Symptoms is Moderated by Smoking: A Case-Control Study.
Article in International journal of methods in psychiatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveSmoking has been linked to both peripheral ghrelin levels and depressive symptoms. However, the association between cerebrospinal fluid (CSF) ghrelin levels and depressive symptoms, and the moderating role of smoking, remains unclear. This study aims to investigate the specific relationship among the three categories.
methodsIn this case-control study, we examined the association between smoking, depressive symptoms, and CSF ghrelin levels in 173 adult male volunteers (94 non-smokers and 79 active smokers). Demographic data, clinical parameters, and Beck Depression Inventory (BDI-SF) scores were assessed, and CSF ghrelin levels were measured. Statistical analyses, including the Mann-Whitney rank-sum test, Spearman correlation, and linear regression, were used to explore the relationships among these variables.
resultsActive smokers had significantly higher BDI scores (3.57 ± 4.74 vs. 1.44 ± 2.33, p < 0.001) and lower CSF ghrelin levels (1201.99 ± 145.97 vs. 1563.61 ± 153.3, p < 0.001) compared with non-smokers. Correlation analysis revealed a significant negative association between CSF ghrelin levels and BDI scores (r = -0.197, p < 0.01). Smoking was positively correlated with BDI scores (r = 0.332, p < 0.001) and negatively correlated with CSF ghrelin levels (r = -0.780, p < 0.001). Moderation analysis further indicated that smoking significantly moderated the association between CSF ghrelin levels and depressive symptoms (Smoking × CSF ghrelin: p = 0.047).
conclusionCSF ghrelin levels are associated with depressive symptoms. A significant negative correlation exists between CSF ghrelin levels and smoking, and smoking appears to moderate the association between CSF ghrelin and depressive symptoms. These findings provide potential insights into the pre-clinical mechanisms of depression and early prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.